Cargando…

1444. Trends in Antimicrobial Non-susceptibility of PCV13-Type Streptococcus pneumoniae Pneumonia in Adults in the United States During 2009–2017

BACKGROUND: The routine use of 13-valent pneumococcal conjugate vaccination (PCV13) was implemented in children in 2010 and in adults (≥65 years of age) in 2014 in the United States. Trends in rates of penicillin G (PEN) antimicrobial nonsusceptibility (NS) for PCV13-type S. pneumoniae from adult pn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendes, Rodrigo E, Suaya, Jose A, Doyle, Timothy B, Woosley, Leah N, Flamm, Robert K, Gessner, Bradford D, Isturiz, Raul E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252960/ http://dx.doi.org/10.1093/ofid/ofy210.1275

Ejemplares similares

Yearly Trends of Antimicrobial Non-susceptibility among Streptococcus pneumoniae Serotypes Causing Infections in Adult Patients in the United States (2009–2015)
por: Mendes, Rodrigo E, et al.
Publicado: (2017)

Distributions and Annual Changes of Streptococcus pneumoniae Serotypes Causing Infections in Adult Patients: Eight Years of US Surveillance (2009–2016)
por: Mendes, Rodrigo E, et al.
Publicado: (2017)

1446. Correlation Between Adult Invasive and Noninvasive Streptococcus pneumoniae Disease in 13-Valent Pneumococcal Conjugate Vaccine Serotypes in the United States
por: Suaya, Jose A, et al.
Publicado: (2018)

1453. Ninety-One Day Quality of Life Post-Pneumonia Diagnosis in Adult Patients in Japan
por: Glick, Henry, et al.
Publicado: (2018)

1442. Pneumonia Hospitalizations Averted With 13-Valent Pneumococcal Conjugate Vaccination of Adults Aged 18–64 Years With Diabetes in the United States
por: Suaya, Jose, et al.
Publicado: (2018)

One-Year Quality of Life Post–Pneumonia Diagnosis in Japanese Adults
por: Glick, Henry A, et al.
Publicado: (2020)

2727. Numbers Needed to Vaccinate for Prevention of Adult Pneumonia with Pneumococcal Conjugate Vaccine: Which Values Should Determine Policy?
por: Gessner, Bradford D, et al.
Publicado: (2019)

Decision-making for PCV in adults
por: McLaughlin, John M., et al.
Publicado: (2018)

Determination of Characteristics of Erythromycin Resistant Streptococcus pneumoniae with Preferred PCV Usage in Iran
por: Talebi, Malihe, et al.
Publicado: (2016)

Genomic surveillance of invasive Streptococcus pneumoniae isolates in the period pre-PCV10 and post-PCV10 introduction in Brazil
por: Almeida, Samanta C. G., et al.
Publicado: (2021)

Serotype Distribution and Antimicrobial Susceptibility of Streptococcus pneumoniae in Pre- and Post- PCV7/13 Eras, Taiwan, 2002–2018
por: Wu, Chi-Jung, et al.
Publicado: (2020)

The Genomics of Streptococcus pneumoniae Carriage Isolates from UK Children and Their Household Contacts, Pre-PCV7 to Post-PCV13
por: Sheppard, Carmen L., et al.
Publicado: (2019)

Burden of Community-Acquired Pneumonia due to PCV-13 Streptococcus pneumoniae Serotypes Among Hospitalized Adults in the United States
por: Ramirez, Julio
Publicado: (2017)

Serotypes and Genotypes of Invasive Streptococcus pneumoniae Before and After PCV10 Implementation in Southern Brazil
por: Caierão, Juliana, et al.
Publicado: (2014)

Antimicrobial Susceptibility/Resistance of Streptococcus Pneumoniae
por: Karcic, Emina, et al.
Publicado: (2015)

Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
por: Bennett, Julia C., et al.
Publicado: (2021)

1440. Potential Impact of Routine Use of 13-Valent Pneumococcal Conjugate Vaccine on Hospitalizations for Pneumonia among Older Adults in Canada
por: Vojicic, Jelena, et al.
Publicado: (2018)

Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults
por: Isturiz, Raul, et al.
Publicado: (2015)

PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
por: Theilacker, Christian, et al.
Publicado: (2022)

Emerging non-PCV13 serotypes of noninvasive Streptococcus pneumoniae with macrolide resistance genes in northern Japan
por: Kawaguchiya, M., et al.
Publicado: (2015)

Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain
por: del Amo, Eva, et al.
Publicado: (2016)

Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain
por: Morales, María, et al.
Publicado: (2018)

Genomic Characteristics of Invasive Streptococcus pneumoniae Serotype 1 in New Caledonia Prior to the Introduction of PCV13
por: Hanachi, Mariem, et al.
Publicado: (2020)

C-Reactive Protein +1444C/T Polymorphism Is Associated with the Susceptibility to Pulmonary Tuberculosis
por: Xu, Yuzhong, et al.
Publicado: (2020)

Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13
por: Redin, A., et al.
Publicado: (2021)

Sandro Botticelli 1444/45-1510
por: Deimling, Barbara
Publicado: (1994)

Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland
por: Chappuy, Hélène, et al.
Publicado: (2013)

Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR)
por: Abu Seir, Rania, et al.
Publicado: (2018)

Genetic diversity of Streptococcus pneumoniae causing meningitis and sepsis in Singapore during the first year of PCV7 implementation
por: Jauneikaite, Elita, et al.
Publicado: (2014)

Identifying an appropriate PCV for use in Senegal, recent insights concerning Streptococcus pneumoniaeNP carriage and IPD in Dakar
por: Ba, Fatim, et al.
Publicado: (2014)

Molecular characterization of Streptococcus pneumoniae causing disease among children in Nigeria during the introduction of PCV10 (GSK)
por: Lo, Stephanie W., et al.
Publicado: (2023)

Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae
por: Murphy, Mark E., et al.
Publicado: (2021)

1452. Non-invasive Pneumococcal Pneumonia in Adults in Portugal: Continued Decline of PCV13 Serotypes (2015–2017)
por: Silva-Costa, Catarina, et al.
Publicado: (2018)

Origin and evolution of MIR1444 genes in Salicaceae
por: Wang, Meizhen, et al.
Publicado: (2017)

The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi
por: Obolski, Uri, et al.
Publicado: (2023)

Antimicrobial Susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997–2016)
por: Sader, Helio S, et al.
Publicado: (2019)

Pneumonia and Streptococcus pneumoniae vaccine
por: Kim, Gyu-Lee, et al.
Publicado: (2017)

Genomic epidemiology of penicillin-non-susceptible Streptococcus pneumoniae
por: Dewé, Tamsin C. M., et al.
Publicado: (2019)

Antimicrobial susceptibility of Streptococcus pneumoniae in adult patients with pneumococcal pneumonia in an urban hospital in Mozambique
por: Bos, Jeannet C, et al.
Publicado: (2014)

Population structure, epidemiology and antibiotic resistance patterns of Streptococcus pneumoniae serotype 5: prior to PCV-13 vaccine introduction in Eastern Gambia
por: Ashu, Eta E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hf0kumcc6p679p6ma31pbo1hdr